Phase II study of belagenpumatucel-L, a transforming growth factor beta-2 antisense gene-modified allogeneic tumor cell vaccine in non-small-cell lung cancer (Q80244014)
Jump to navigation
Jump to search
scientific article published on 11 September 2006
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase II study of belagenpumatucel-L, a transforming growth factor beta-2 antisense gene-modified allogeneic tumor cell vaccine in non-small-cell lung cancer |
scientific article published on 11 September 2006 |
Statements
Phase II study of belagenpumatucel-L, a transforming growth factor beta-2 antisense gene-modified allogeneic tumor cell vaccine in non-small-cell lung cancer (English)
John Nemunaitis
Robert O Dillman
Paul O Schwarzenberger
Neil Senzer
Casey Cunningham
Jodi Cutler
Alex Tong
Padmasini Kumar
Beena Pappen
Cody Hamilton
Edward DeVol
Phillip B Maples
Lily Liu
Terry Chamberlin
Daniel L Shawler
11 September 2006